| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | — | +0.0% |
| R&D Expense | $25.2M | -10.4% | +26.9% |
| SG&A Expense | $7.8M | -7.1% | +13.1% |
| Operating Income | -$33.0M | +9.6% | -36.1% |
| Pre-tax Income | -$30.1M | +10.7% | -20.2% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$30.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $316.8M | +19.7% | +111.7% |
| Short-term Investments | $67.2M | — | — |
| Current Assets | $391.3M | +44.3% | — |
| Total Assets | $422.1M | +39.1% | — |
| Current Liabilities | $22.1M | +11.1% | — |
| Total Liabilities | $42.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$84.2M | — | — |
| Capital Expenditures | $760K | — | — |
| Investing Cash Flow | -$67.6M | — | — |
| Financing Cash Flow | $271.7M | — | — |
| Free Cash Flow | -$85.0M | — | — |
| -21.6% |
| EPS (Basic) | -$0.66 | +14.3% | +93.6% |
| EPS (Diluted) | -$0.66 | +14.3% | +93.6% |
| +3.2% |
| — |
| Stockholders' Equity | $379.4M | +44.7% | +233.4% |